MS Views and News Be empowered with MS views and news. To receive The MS BEACON e-Newsletter, CLICK HERE - -

Visit our MS learning channel on YouTube, which provides hundreds of MS educational videos presented by MS Experts from across the USA. Archived here: -- Also please visit our Social media platforms: Facebook, Twitter, and Instagram . Each providing important information for the MS community. Furthermore, scroll down the left side of this blog to learn from the resources and links.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, for your personal knowledge and to keep you informed of current health-related issues. It is not a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.


Wednesday, October 1, 2014

Pilot Study Finds Stem Cell Treatment Safe for MS Patients

Source: MSFYI newsletter - August 2014

Researchers found that stem cell transplantation may be safe and feasible for MS patients. Using stem cells harvested from the bone marrow of the test subjects, the Phase I study suggests that the procedure deserves further study.

Following up on prior studies that found that stem cells were safe and effective in the treatment of other diseases, 24 participants with relapsing forms of MS were involved in a study that tested the use of bone-marrow-derived, culture-expanded Mesenchymal stem cells (MSCs). Led by Dr. Jeffrey Cohen of the Cleveland Clinic, researchers injected 16 women and eight men – 10 with relapsing-remitting and 14 with secondary-progressive MS – with MSCs and found that cell infusion was well-tolerated, and there were no treatment-related severe or serious adverse events.

While neither disease activation nor significant improvement was observed, researchers said that future trials to assess efficacy more definitively are warranted.

Cohen’s research was presented at the ACTRIMS-ECTRIMS MS Boston 2014.

 Keep CURRENT and up to date, 
Sign-Up for our email

WATCH OUR Multiple Sclerosis recorded


No comments: